Mrs. Chaya Mazouz, prior to joining LipoCure, held the position of VP Clinical and Regulatory Affairs at Pluristem Ltd., a bio-therapeutics company dedicated to the commercialization of allogeneic cell therapy products derived from human placenta. Before working at Pluristem, Mrs. Mazouz held the position of Clinical Operations Director at Medgenics, a clinical-stage biopharmaceutical company involved in gene therapy, where she engineered and managed Phase I/II clinical studies. Previously, Mrs. Mazouz served as Clinical Manager for TransPharma Medical, a drug delivery company, where she was responsible for managing clinical activities. In previous positions, she led a multi-center Phase II study for Pharmos, a pharmaceutical company, and was CRA and Project Manager at IDgene, a startup company engaged in gene discovery. Mrs. Mazouz brings a broad range of clinical and quality assurance expertise, and has broad related experience from the pharmaceutical and biotechnology industries in Israel. Mrs. Mazouz holds a B.Sc. from the Hebrew University of Jerusalem.